• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

265.3450 USD 4.4450 1.70%

As of 12:15:10 ET on 12/18/2014.

Snapshot for Actavis plc (ACT)

Open: 264.7000 Day's Range: 263.1100 - 268.3700 Volume: 1,196,648
Previous Close: 260.9000 52wk Range: 156.4000 - 272.7500 1-Yr Rtn: +60.92%

Stock Chart for ACT

No chart data available.
  • ACT:US 265.3200
  • 1D
  • 1M
  • 1Y
260.9000
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 51.9401
Estimated P/E(12/2014) 19.5518
Relative P/E vs. SPX 2.9472
Earnings Per Share (USD) (ttm) 5.1126
Est. EPS (USD) (12/2014) 13.5760
Est. PEG Ratio 1.0167
Market Cap (M USD) 70,386.98
Shares Outstanding (M) 265.06
30 Day Average Volume 3,722,856
Price/Book (mrq) 2.4122
Price/Sale (ttm) 4.3831
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
Maria Teresa Hilado "Tessa"Chief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil